Literature DB >> 8341221

Tumor lysis syndrome after combination chemotherapy for ovarian cancer.

S F Bilgrami1, B G Fallon.   

Abstract

Tumor lysis syndrome is infrequently encountered following the treatment of solid tumors. A 47-year-old woman developed this syndrome after receiving combination chemotherapy for ovarian cancer. The levels of serum lactate dehydrogenase, uric acid, phosphate, and creatinine increased, whereas the serum calcium level decreased. These metabolic abnormalities were treated successfully using a combination of vigorous intravenous hydration, parenteral bicarbonate to keep urinary pH > 7, furosemide, and allopurinol. This unusual and easily treatable complication should be anticipated in patients with rapidly growing ovarian cancer undergoing aggressive treatment.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8341221     DOI： 10.1002/mpo.2950210712

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN： 0098-1532


  9 in total

1.  Acute tumor lysis syndrome triggered by zoledronic Acid in a patient with metastatic lung adenocarcinoma.

Authors:  Mevlut Kurt; Ibrahim K Onal; Tamer Elkiran; Bulent Altun; Kadri Altundag; Ibrahim Gullu
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

2.  A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer.

Authors:  Melissa A Geller; Sarah Cooley; Patricia L Judson; Rahel Ghebre; Linda F Carson; Peter A Argenta; Amy L Jonson; Angela Panoskaltsis-Mortari; Julie Curtsinger; David McKenna; Kathryn Dusenbery; Robin Bliss; Levi S Downs; Jeffrey S Miller
Journal:  Cytotherapy       Date:  2010-09-20       Impact factor: 5.414

3.  Tumour lysis syndrome in a patient with intravascular spread from a recurrent epithelial ovarian cancer.

Authors:  Michelle Camarata; Roger Davies; Sue Copley; Sarah Blagden
Journal:  BMJ Case Rep       Date:  2013-04-23

4.  An unusual presentation of tumor lysis syndrome in a patient with advanced gastric adenocarcinoma: case report and literature review.

Authors:  Danica Maria Vodopivec; Jose Enrique Rubio; Alessia Fornoni; Oliver Lenz
Journal:  Case Rep Med       Date:  2012-05-27

Review 5.  Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout.

Authors:  Lisa Cammalleri; Mariano Malaguarnera
Journal:  Int J Med Sci       Date:  2007-03-02       Impact factor: 3.738

6.  Tumor lysis without syndrome in adenocarcinoma of the lung: Case report.

Authors:  Amit Chopra; Creticus Marak; Narendra Kumar Alappan; Daniel Alterman; Chang Shim
Journal:  Respir Med Case Rep       Date:  2013-09-07

7.  A Case of Spontaneous Tumor Lysis Syndrome in a Patient with Ovarian Cancer.

Authors:  Kazuhiro Okamoto; Toshifumi Kinoshita; Miyuki Shimizu; Isoji Okura; Akinori Kawada; Koichi Mizobuchi; Midori Ando
Journal:  Case Rep Obstet Gynecol       Date:  2015-06-16

8.  A Case Report of Newly Diagnosed Epithelial Ovarian Carcinoma Presenting with Spontaneous Tumor Lysis Syndrome and Its Successful Management with Rasburicase.

Authors:  Deepak Kumar Shukla; Dinesh Gupta; Arun Aggarwal; Deepak Kumar
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Jul-Sep

Review 9.  Tumor Lysis Syndrome in Solid Tumors: An up to Date Review of the Literature.

Authors:  Aibek E Mirrakhimov; Alaa M Ali; Maliha Khan; Aram Barbaryan
Journal:  Rare Tumors       Date:  2014-06-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.